Citigroup’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-582,275
| Closed | -$454K | – | 4857 |
|
|
2023
Q3 | $454K | Buy |
582,275
+79
| +0% | +$62 | ﹤0.01% | 2481 |
|
|
2023
Q2 | $539K | Buy |
582,196
+580,541
| +35,078% | +$537K | ﹤0.01% | 2690 |
|
|
2023
Q1 | $1.8K | Sell |
1,655
-307
| -16% | -$335 | ﹤0.01% | 4383 |
|
|
2022
Q4 | $2.87K | Sell |
1,962
-4,687
| -70% | -$6.84K | ﹤0.01% | 4396 |
|
|
2022
Q3 | $7K | Sell |
6,649
-24,782
| -79% | -$26.1K | ﹤0.01% | 4339 |
|
|
2022
Q2 | $53K | Buy |
31,431
+9,894
| +46% | +$16.7K | ﹤0.01% | 3833 |
|
|
2022
Q1 | $44K | Sell |
21,537
-8,512
| -28% | -$17.4K | ﹤0.01% | 4070 |
|
|
2021
Q4 | $113K | Sell |
30,049
-11,942
| -28% | -$44.9K | ﹤0.01% | 3903 |
|
|
2021
Q3 | $217K | Sell |
41,991
-7,932
| -16% | -$41K | ﹤0.01% | 3344 |
|
|
2021
Q2 | $213K | Sell |
49,923
-36,078
| -42% | -$154K | ﹤0.01% | 3552 |
|
|
2021
Q1 | $457K | Buy |
86,001
+37,498
| +77% | +$199K | ﹤0.01% | 2885 |
|
|
2020
Q4 | $261K | Buy |
48,503
+47,441
| +4,467% | +$255K | ﹤0.01% | 3071 |
|
|
2020
Q3 | $8K | Buy |
1,062
+69
| +7% | +$520 | ﹤0.01% | 4415 |
|
|
2020
Q2 | $10K | Sell |
993
-1,189
| -54% | -$12K | ﹤0.01% | 4622 |
|
|
2020
Q1 | $6K | Buy |
2,182
+2,162
| +10,810% | +$5.95K | ﹤0.01% | 4764 |
|
|
2019
Q4 | $0 | Sell |
20
-2,164
| -99% | – | ﹤0.01% | 5078 |
|
|
2019
Q3 | $3K | Buy |
2,184
+35
| +2% | +$48 | ﹤0.01% | 4876 |
|
|
2019
Q2 | $9K | Buy |
2,149
+1,014
| +89% | +$4.25K | ﹤0.01% | 4767 |
|
|
2019
Q1 | $5K | Buy |
+1,135
| New | +$5K | ﹤0.01% | 4873 |
|
|
2018
Q4 | – | Sell |
-6,175
| Closed | -$84K | – | 4990 |
|
|
2018
Q3 | $84K | Hold |
6,175
| – | – | ﹤0.01% | 3704 |
|
|
2018
Q2 | $73K | Buy |
6,175
+5,893
| +2,090% | +$69.7K | ﹤0.01% | 3632 |
|
|
2018
Q1 | $3K | Sell |
282
-1,564
| -85% | -$16.6K | ﹤0.01% | 4683 |
|
|
2017
Q4 | $12K | Buy |
+1,846
| New | +$12K | ﹤0.01% | 4425 |
|
|
2016
Q2 | – | Sell |
-1
| Closed | – | – | 4929 |
|
|
2016
Q1 | $0 | Buy |
+1
| New | – | ﹤0.01% | 5308 |
|
|
2015
Q4 | – | Sell |
-5,211
| Closed | -$62K | – | 5368 |
|
|
2015
Q3 | $62K | Buy |
+5,211
| New | +$62K | ﹤0.01% | 3428 |
|